STOMPP Study Demonstrates Multimed Packaging Improves Medication Adherence
In the STOMPP study, patients were randomly assigned to one of four groups based on whether they received their medications dispensed in vials (pill bottles) vs. multimed blister packaging, and whether or not they received pharmacist-provided MTM. While improvements with use of multimed packaging and MTM services were proven individually and in combination, study participants who received multimed blister cards had the most marked change in adherence scores when compared to pill bottle groups, achieving adherence scores greater than 45 percent above baseline.
Further evidence of the benefits of multimed packaging as demonstrated by the STOMPP study is highlighted below:
- Patients assigned to the multimed packaging groups reached medication adherence rates of 80 percent almost immediately upon enrollment.
- These patients achieved 90 percent adherence rates by the end of the one-year study period.
- By contrast, patients assigned to the pill bottle-only group reached a maximum of 56 percent adherence.
To combat the
"As a nation, we need to do a better job at managing complex patients, as 80 million patients are expected to have more than one chronic condition by 2030,"ii said Dr.
The primary endpoint of STOMPP, measured at one year, was to determine if the use of adherence packaging and/or medication therapy management in the hybrid pharmacy practice model has an impact on medication adherence. The study followed patients within a regional integrated delivery network (IDN) who had been diagnosed with type 2 diabetes, hypertension, and/or hyperlipidemia for one year to assess clinical outcome measures, quality of life, and cost and utilization data.
At baseline, most patients were on approximately 10 prescription medications, had a body mass index of more than 30, and uncontrolled diabetes with HbA1c greater than seven percent. Patients were randomized into four groups where they received pill bottle medications, blister packaging, pill bottles and MTM, or blister packaging and MTM.
Other study findings include:
- Patients who received multimed packaging reached their blood pressure goals sooner than those who did not use multimed packaging;
- Patients who only received their medications in pill vials with no other pharmacy-based services had the poorest health outcomes, incurred higher costs, and utilized more healthcare resources than patients in other groups;
- Patients who received multimed packaging and MTM had the lowest average HbA1c values (used to measure average blood sugar levels) at the end of the year when compared to the other groups.
"Our pharmacy partners know the impact they can have on patient care when they're able to offer additional resources to their patients. The STOMPP study formalizes what we have known as an industry for years, and allows these providers to advocate for a greater involvement in patient care teams moving forward," said
Dr. Pinto served as the study's Principal Investigator and lead researcher. The results were presented at the
The STOMPP study was funded through an unrestricted grant from
Supporting the highest level of patient safety is essential to excellent patient care. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems,
For more information about Omnicell, Inc. please visit www.omnicell.com.
Omnicellnews releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website, omnicell.com. Omnicelland the Omnicelllogo design are registered trademarks of Omnicell, Inc.
- All other brand or product names may be trademarks or registered trademarks of their respective companies.
i Annals of Internal Medicine. "Interventions to Improve Adherence to Self-administered Medications for Chronic Diseases in the United States: A Systematic Review," last accessed March 6, 2018. http://annals.org/aim/fullarticle/1357338/interventions-improve-adherence-self-administered-medications-chronic-diseases-united-states
ii Centers for Medicare and Medicaid Services, "Chronic care management: Is the $50 billion market more hype than reality?" last accessed March 6, 2018. http://www.healthcareitnews.com/news/chronic-care-management-50-billion-market-more-hype-reality
View original content with multimedia:http://www.prnewswire.com/news-releases/stompp-study-demonstrates-multimed-packaging-improves-medication-adherence-300664728.html
Sarah Sweeny, Omnicell, Inc., (727) 576-6311, email@example.com; Jessika Parry, Next Step Communications, (781) 326-1741, firstname.lastname@example.org